Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Hongkong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. Nieuws
  7. Andere talen
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Rapport
Vertraagde tijd Hong Kong Stock Exchange  -  03:55 09-12-2022
4.490 HKD   -0.22%
21/11Sectorupdate: aandelen in de gezondheidszorg gaan licht vooruit
MT
02/11De omzet van Sino Biopharmaceutical in het derde kwartaal stijgt met 21%; aandelen stijgen met 5%.
MT
02/11Sino Biopharmaceutical Limited geeft omzetbegeleiding voor 2023
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SINO BIOPHARMACEUTICAL LIMITED
21/11Sector Update: Health Care Stocks Advance Modestly
02/11Sino Biopharmaceutical's Q3 Revenue Rises 21%; Shares Rise 5%
02/11Sino Biopharmaceutical Limited Provides Revenue Guidance for 2023
02/11Sino Biopharmaceutical Limited Reports Unaudited Revenue Results for the Third Quarter ..
02/11Sino Biopharmaceutical Limited Announces Resignation of Wang Shanchun as Executive Dire..
30/09Trustee Purchases Sino Biopharmaceutical Shares for $1.3 Million
29/09Trustee Purchases 2,780,000 Sino Biopharmaceutical Shares for $1.3 Million
27/09Chinese Regulator Approves Clinical Trial of Sino Biopharmaceutical's COVID-19 Medicine..
22/09Inventiva ADRs Rise 22% After Licensing Deal With Chia Tai-Tianqing Pharma
22/09Chia Tai-Tianqing Signs Agreement for Lanifibranor
21/09Sino Biopharmaceutical Trustee Purchases Shares for $1 Million
20/09Sino Biopharmaceutical Trustee Purchases Additional $1 Million Shares
09/09HanchorBio Inc. announced that it has received $10 million in funding from Zero2IPO Ven..
07/09Sino Biopharmaceutical Limited announces an Equity Buyback for 1,882,009,423 shares, re..
29/08China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
23/08Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to ..
23/08Sino Biopharmaceutical Limited Announces Interim Cash Dividend for the period ended 30 ..
23/08Sino Biopharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30..
12/08Hong Kong Hang Seng Up 0.5% As Property and Tech Sectors Edge Higher
28/07Sino Biopharmaceutical CEO Resigns
27/07Sino Biopharmaceutical Limited Announces CEO Changes, Effective July 28, 2022
27/07Sino Biopharmaceutical Limited Announces Resignation of Li Yi as Executive Director
07/07Generon Corporation Ltd. announced that it has received $70.000203 million in funding f..
30/06Hong Kong Hang Seng Down 0.6% As Tech Issues Weaken
27/06Sino Biopharmaceutical Submits Application for Marketing of Anti-Tumor Capsule
27/06Sino Biopharmaceutical Limited Announces Application for Marketing of Category 1 Anti-T..
24/06Sino Biopharmaceutical to Buy Nasdaq-listed F-Star Therapeutics for $161 Million; Share..
23/06Sector Update: Health Care Stocks Lead Thursday Markets Recovery
23/06Sector Update: Health Care Stocks Again Outpacing Other Sectors to the Ups..
23/06Sector Update: Health Care
23/06Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday
23/06Sector Update: Health Care
23/06F-star Therapeutics Shares Soar on Buyout Deal
23/06Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million
23/06InvoX Pharma to Buy F-star Therapeutics in $161 Million Deal
20/06Sino Biopharmaceutical Adjusts Conversion Price for Convertible Bonds
14/06Sino Biopharmaceutical Obtains China Approval for Anti-Asthma Injectable Clinical Trial..
14/06Sino Biopharmaceutical Limited Announces Approval of Category 1 Innovative Drug TQC2938..
13/06SciClone Pharma Hires Former Sino Biopharma Exec as Chief Medical Officer; Shares Slide..
07/06Hong Kong Hang Seng Down 0.6% As Tech Rally Stalls
06/06Sino Biopharmaceutical Limited's Equity Buyback announced on July 27, 2021, has expired..
01/06Generon Corporation Ltd. announced that it expects to receive $70 million in funding fr..
24/05China Accepts Sino Biopharm's Marketing Application for Cancer Drug
24/05Sino Biopharm Buys Back $278 Million of Euro-Denominated Bonds
23/05Sino Biopharmaceutical Submits Application for Marketing of the Category I Anti-Tumor I..
23/05Sino Biopharm Repurchases $168 Million of Euro-Denominated Bonds
19/05Sino Biopharm Unit to Purchase Tumor Inhibitor of Danish Biotech Firm Symphogen
11/05Hong Kong Stocks Rebound from Near Two-Month Low; Biotech Shares Rally
05/05Sino Biopharm Repurchases $86.5 Million of Euro-Denominated Bonds
25/04Sino Biopharmaceutical Signs License Deal for Hepatitis, Diabetes Drugs
20/04Sino Biopharm Gets Clearance to Start China Clinical Trial of Anti-Tumor Drug
20/04Sino Biopharmaceutical Limited's Category I Anti-Tumor Innovative Drug "TQB2930" Obtain..
19/04Sino Biopharmaceutical Limited Announces Anlotinib Hydrochloride Capsules Obtains Appro..
08/04Sino Biopharmaceutical's TQ-B3525 Drug Gets Breakthrough Therapy Drug Designation from ..
08/04Chinese Drug Regulator Accepts Sino Biopharmaceutical's Respiratory Diseases Injection ..
08/04Sino Biopharmaceutical Limited Announces Innovative Drug "TQ-B3525" Was Included in the..
07/04Sino Biopharmaceutical Limited Announces That Application for Clinical Trial of "TQC293..
04/04Sino Biopharm's New Product Launches Propel Profit by 427% in 2021
04/04Sino Biopharm Unveils Share Buyback, Boosts Dividend as 2021 Profit Soars 427%
01/04Hong Kong Hang Seng Index Up 0.2% in Late Rally
31/03Sino Biopharmaceutical Limited Proposes Final Dividend for the Final Dividend for 2021,..
31/03Sino Biopharmaceutical Limited Reports Earnings Results for the Full Year Ended Decembe..
29/03Chinese Regulators OK Sino Biopharma's Clinical Trial of Solid Tumor Treatment
29/03Sino Biopharm Wins Nod to Start China Clinical Trial of Solid Tumor Drug
29/03Sino Biopharmaceutical Limited Announces Category I Anti-Tumour Innovative Medicine FHN..
18/03Sino Biopharma Partners With Shenzhen XtalPi for Anti-Tumor Drug Development
17/03Sino Biopharm's Drug for Overactive Bladder Wins Registration Approval in China; Shares..
16/03Sino Biopharmaceutical Limited Announces Mirabegron Sustained-Release Tablets Obtained ..
16/03Sino Biopharm Sees Up to Fivefold Increase in 2021 Profit; Shares Jump 7%
16/03Sino Biopharm's Antibiotic Wins Marketing Approval, Generic Status in China; Shares Ris..
15/03Sino Biopharmaceutical Limited Announces Linezolid Tablets Obtained Drug Registration C..
15/03Sino Biopharmaceutical Limited Provides Group Earnings Guidance for the Year Ended 31 D..
15/03US FDA OKs Sino Biopharma's Abbreviated NDA for Blood Lipid-Lowering Drug
14/03Sino Biopharmaceutical Limited Announces Colesevelam Hydrochloride Tablets Obtained AND..
14/03China Approves Market Launch of Sino Biopharm's Antipsychotic Medication
14/03Sino Biopharmaceutical Limited's Lurasidone Hydrochloride Tablets Obtains Drug Registra..
11/03Japanese Regulators Allow Sino Biopharma to Sell Anti-Rheumatic Drug
11/03Sino Biopharma Arm Partners With Biocytogen Pharmaceuticals for Antibody Drugs Developm..
10/03Chinese Regulators Grant Drug Registration Certificate to Sino Bio's Generic Rheumatoid..
10/03Chinese Regulators Grant Drug Registration Certificates to Sino Bio's Generic Diabetes ..
10/03Sino Biopharmaceutical Limited Announces Sitagliptin Phosphate Tablet
10/03Sino Biopharmaceutical Limited Obtains Drug Registration Certificate
09/03Sino Biopharm Wins Greenlight to Start China Clinical Trial of Pneumoconiosis Treatment..
08/03National Medical Products Administrations of China Approves Sino Biopharmaceutical Limi..
28/02Hong Kong Hang Seng Down 0.2% on Ukraine, Pandemic Outlooks
14/02Hong Kong Lowers Minimum Age to Get Sinovac Jab to Three Amid Raging Omicron Outbreak
25/01China stocks fall ahead of Fed meeting, Lunar New Year
21/01Sino Biopharm's Anti-Rheumatic Drug Wins Marketing Approval in China
20/01Sino Biopharmaceutical Limited Announces Approval of "Adalimumab Solution for Injection..
11/01Chinese Regulators OK Sino Biopharma's Generic Diabetes Treatment for Marketing in Chin..
10/01Sino Biopharmaceutical Limited Announces Sitagliptin Phosphate and Metformin Hydrochlor..
04/01DNA Script SAS announced that it has received €177.12 million in funding from a gr..
03/01Hong Kong Hang Seng Sheds 0.5% as Property Issues Renew Slump
2021Sino Biopharmaceutical Buys Back 4.5 Million More Shares
2021Sino Biopharm Wins Nod to Start China Clinical Trial of Cough Medicine
2021Sino Biopharmaceutical to Become Sole Sales Agent of Hodgkin's Lymphoma Treatment Produ..
2021Sino Biopharmaceutical Limited's TCR1672 Obtains Approval for Clinical Trial
2021Sino Biopharmaceutical Limited Enters into an Exclusive Sales Agreement with CTTQ-Akeso..
2021Hong Kong Hang Seng Up 0.2% As Property, Tech Sectors Lift
2021Hong Kong Hang Seng Down 0.9% on New US Sanctions Reports
Volgende evenement op SINO BIOPHARMACEUTICAL LIMITED